Abstract |
The present patient was a 53-year-old male who had large cell lung cancer of c-T4N1M0. We administered multi-drug regimen including mitomycin C, vindesine and cisplatin (CDDP) because of cancer invasion into the great vessels seen on a chest CT. After 3 courses, the cancer showed no change in size. Therefore, we adopted chemotherapy of docetaxel ( Taxotere: TXT) and CDDP. After 4 courses, the size of the mass had decreased (partial response). The only major toxic defect was grade 3 neutropenia. A good response to TXT and CDDP could lead to complete resection of lung cancer. It is suggested that TXT is effective in the treatment of large cell lung cancer.
|
Authors | T Saito, T Ishida, H Aoki, K Kuwahara, Y Minegishi, K Watanabe, T Okano, K Hashimoto, K Hayashihara, S Watanabe, E Nemoto, S Fukai, N Yanai |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 27
Issue 13
Pg. 2109-12
(Nov 2000)
ISSN: 0385-0684 [Print] Japan |
PMID | 11103243
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Taxoids
- Docetaxel
- Mitomycin
- Paclitaxel
- Cisplatin
- Vindesine
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Carcinoma, Large Cell
(drug therapy)
- Cisplatin
(administration & dosage)
- Docetaxel
- Drug Administration Schedule
- Humans
- Lung Neoplasms
(drug therapy)
- Male
- Middle Aged
- Mitomycin
(administration & dosage)
- Paclitaxel
(administration & dosage, analogs & derivatives)
- Taxoids
- Treatment Failure
- Vindesine
(administration & dosage)
|